Phenyl-piperazine derivatives as serotonin reuptake inhibitors
AssigneeH. Lundbeck A/S
InventorBenny Bang-Andersen
Life of this patent
Estimating the term…
Abstract
The invention provides compounds represented by the general formula I wherein the substituents are defined in the application. The compounds are useful in the treatment of an affective disorder, including depression, anxiety disorders including general anxiety disorder and panic disorder and obsessive compulsive disorder.
Claims21
A pharmaceutical composition comprising the compound 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine or a pharmaceutically acceptable acid addition salt thereof, and at least one pharmaceutically acceptable carrier or diluent.
A method for the treatment of an affective disorder in an animal, comprising administering a therapeutically effective amount of the compound 1-[-2-[2,4-dimethylphenylsulfanyl)phenyl]piperazine or a pharmaceutically acceptable acid addition salt thereof to said animal.
Dependencies are inferred from the claim text.